Michael Piontek

807 total citations
27 papers, 528 citations indexed

About

Michael Piontek is a scholar working on Molecular Biology, Biomedical Engineering and Biotechnology. According to data from OpenAlex, Michael Piontek has authored 27 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Biomedical Engineering and 5 papers in Biotechnology. Recurrent topics in Michael Piontek's work include Biofuel production and bioconversion (7 papers), Fungal and yeast genetics research (7 papers) and HIV Research and Treatment (3 papers). Michael Piontek is often cited by papers focused on Biofuel production and bioconversion (7 papers), Fungal and yeast genetics research (7 papers) and HIV Research and Treatment (3 papers). Michael Piontek collaborates with scholars based in Germany, Australia and United States. Michael Piontek's co-authors include Gotthard Kunze, Erik Böer, Cornelis P. Hollenberg, Rüdiger Bode, Alexander W.M. Strasser, Zbigniew A. Janowicz, Gerd Gellissen, Ulrike Weydemann, Manfred Suckow and Hans‐Peter Mock and has published in prestigious journals such as Nature Biotechnology, PLoS ONE and Neurology.

In The Last Decade

Michael Piontek

27 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Piontek Germany 15 329 124 117 64 47 27 528
Wangrong Yang United States 9 113 0.3× 37 0.3× 38 0.3× 17 0.3× 14 0.3× 10 436
Miguel Arévalo-Rodrı́guez Spain 16 615 1.9× 77 0.6× 46 0.4× 96 1.5× 3 0.1× 22 842
Qiao Lin China 15 568 1.7× 69 0.6× 16 0.1× 43 0.7× 5 0.1× 49 936
Tomasz Bogiel Poland 15 343 1.0× 51 0.4× 11 0.1× 8 0.1× 26 0.6× 74 717
Sanjay Pal India 14 268 0.8× 35 0.3× 40 0.3× 50 0.8× 2 0.0× 43 582
William Moens Belgium 12 325 1.0× 32 0.3× 36 0.3× 226 3.5× 5 0.1× 29 591
Antonio L. C. Gomes United States 14 484 1.5× 69 0.6× 28 0.2× 46 0.7× 3 0.1× 31 691
Kathy N. Lam Canada 11 637 1.9× 37 0.3× 37 0.3× 105 1.6× 3 0.1× 13 784
Paramjit Singh India 16 304 0.9× 53 0.4× 32 0.3× 120 1.9× 2 0.0× 61 748
Eleftheria Lamprianidou Greece 10 327 1.0× 17 0.1× 97 0.8× 31 0.5× 4 0.1× 20 554

Countries citing papers authored by Michael Piontek

Since Specialization
Citations

This map shows the geographic impact of Michael Piontek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Piontek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Piontek more than expected).

Fields of papers citing papers by Michael Piontek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Piontek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Piontek. The network helps show where Michael Piontek may publish in the future.

Co-authorship network of co-authors of Michael Piontek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Piontek. A scholar is included among the top collaborators of Michael Piontek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Piontek. Michael Piontek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kurtovic, Liriye, Linda Reiling, Damien R. Drew, et al.. (2021). Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice. Frontiers in Immunology. 12. 641421–641421. 13 indexed citations
2.
Chan, Jo-Anne, Manfred Suckow, Linda Reiling, et al.. (2019). Display of malaria transmission-blocking antigens on chimeric duck hepatitis B virus-derived virus-like particles produced in Hansenula polymorpha. PLoS ONE. 14(9). e0221394–e0221394. 14 indexed citations
3.
Schembecker, Gerhard, et al.. (2019). Bioprocess optimization for purification of chimeric VLP displaying BVDV E2 antigens produced in yeast Hansenula polymorpha. Journal of Biotechnology. 306. 203–212. 18 indexed citations
4.
Chan, Jo-Anne, Linda Reiling, Kazutoyo Miura, et al.. (2019). Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity. PLoS ONE. 14(9). e0221733–e0221733. 19 indexed citations
6.
Suckow, Manfred, Andreas Kranz, Jo-Anne Chan, et al.. (2018). Establishment of a yeast-based VLP platform for antigen presentation. Microbial Cell Factories. 17(1). 17–17. 29 indexed citations
7.
Kranz, Andreas, et al.. (2013). Synthesis and release of the bacterial compatible solute 5-hydroxyectoine in Hansenula polymorpha. Journal of Biotechnology. 167(2). 85–93. 27 indexed citations
8.
Hollenberg, Cornelis P., et al.. (2012). Improved processing of secretory proteins in Hansenula polymorpha by sequence variation near the processing site of the alpha mating factor prepro sequence. Journal of Biotechnology. 167(2). 94–100. 5 indexed citations
9.
Giersberg, Martin, et al.. (2012). Production of a thermostable alcohol dehydrogenase from Rhodococcus ruber in three different yeast species using the Xplor®2 transformation/expression platform. Journal of Industrial Microbiology & Biotechnology. 39(9). 1385–1396. 16 indexed citations
10.
Hollenberg, Cornelis P., et al.. (2011). The use of highly expressed FTH1 as carrier protein for cytosolic targeting in Hansenula polymorpha. Journal of Biotechnology. 159(3). 172–176. 13 indexed citations
11.
Böer, Erik, et al.. (2011). Large-scale production of tannase using the yeast Arxula adeninivorans. Applied Microbiology and Biotechnology. 92(1). 105–114. 27 indexed citations
12.
Kaur, Parvinder, Bijender Singh, Erik Böer, et al.. (2010). Pphy—A cell-bound phytase from the yeast Pichia anomala: Molecular cloning of the gene PPHY and characterization of the recombinant enzyme. Journal of Biotechnology. 149(1-2). 8–15. 14 indexed citations
15.
Böer, Erik, Michael Piontek, & Gotthard Kunze. (2009). Xplor® 2—an optimized transformation/expression system for recombinant protein production in the yeast Arxula adeninivorans. Applied Microbiology and Biotechnology. 84(3). 583–594. 37 indexed citations
16.
Böer, Erik, Rüdiger Bode, Hans‐Peter Mock, Michael Piontek, & Gotthard Kunze. (2009). Atan1p—an extracellular tannase from the dimorphic yeast Arxula adeninivorans: molecular cloning of the ATAN1 gene and characterization of the recombinant enzyme. Yeast. 26(6). 323–337. 65 indexed citations
17.
Piontek, Michael & Rainer Porschen. (1994). Growth inhibition of human gastrointestinal cancer cells by cyclosporin A. Journal of Cancer Research and Clinical Oncology. 120(12). 695–699. 4 indexed citations
18.
Piontek, Michael, et al.. (1992). Spinal abscess and bacterial meningitis in Crohn's disease. Digestive Diseases and Sciences. 37(7). 1131–1135. 10 indexed citations
19.
Gellissen, Gerd, Karl Melber, Zbigniew A. Janowicz, et al.. (1992). Heterologous protein production in yeast. Antonie van Leeuwenhoek. 62(1-2). 79–93. 60 indexed citations
20.
Gellissen, Gerd, Zbigniew A. Janowicz, Armin Merckelbach, et al.. (1991). Heterologous Gene Expression in Hansenula Polymorpha: Efficient Secretion of Glucoamylase. Nature Biotechnology. 9(3). 291–295. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026